EUVIMEDEUVIMED entdecken
Crossref

Self‐Assembled PD‐L1 Downregulator to Boost Photodynamic Activated Tumor Immunotherapy Through CDK5 Inhibition

Bai-Xue Yu, Yi-Bin Liu, Xia-Yun Chen, Wei Zhang, Yi Cen, Meng-Yi Yan, Qian-Qian Liu, Shi-Ying Li iD

Small · 2024

DOI: 10.1002/smll.202311507 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, 2024. Verfasst von Bai-Xue Yu und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Fifth Affiliated Hospital, Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology the NMPA and State Key Laboratory of R…. Hauptthemen laut MEDLINE: Photochemotherapy, B7-H1 Antigen, Immunotherapy, Cyclin-Dependent Kinase 5. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The immunosuppressive characteristics and acquired immune resistance can restrain the therapy‐initiated anti‐tumor immunity. In this work, an antibody free programmed death receptor ligand 1 (PD‐L1) downregulator (designated as CeSe) is fabricated to boost photodynamic activated immunotherapy through cyclin‐dependent kinase 5 (CDK5) inhibition. Among which, FDA approved photosensitizer of chlorin e6 (Ce6) and preclinical available CDK5 inhibitor of seliciclib (Se) are utilized to prepare the nanomedicine of CeSe through self‐assembly technique without drug excipient. Nanoscale CeSe exhibits an increased stability and drug delivery efficiency, contributing to intracellular production of reactive oxygen species (ROS) for robust photodynamic therapy (PDT). The PDT of CeSe can not only suppress the primary tumor growth, but also induce the immunogenic cell death (ICD) to release tumor associated antigens. More importantly, the CDK5 inhibition by CeSe can downregulate PD‐L1 to re‐activate the systemic anti‐tumor immunity by decreasing the tumor immune escape and therapy‐induced acquired immune resistance. This work provides an antibody free strategy to activate systemic immune response for metastatic tumor treatment, which may accelerate the development of translational nanomedicine with sophisticated mechanism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhotochemotherapyB7-H1 AntigenImmunotherapyCyclin-Dependent Kinase 5AnimalsHumansCell Line, TumorDown-RegulationMiceNeoplasmsPorphyrinsReactive Oxygen SpeciesChlorophyllides

Stichwörter der Autor:innen

cyclin‐dependent kinase 5 (CDK5)immunogenic cell deathimmunotherapyphotodynamic therapyprogrammed death receptor ligand 1 (PD‐L1)

Substanzen

B7-H1 AntigenCyclin-Dependent Kinase 5PorphyrinsReactive Oxygen SpeciesChlorophyllides

Autor:innen und Institutionen

  • The Fifth Affiliated Hospital, Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology the NMPA and State Key Laboratory of Respiratory Disease, the School of Pharmaceutical Sciences, Guangzhou M…

ORCID-Profile: Shi-Ying Li

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Basic and Applied Basic Research Foundation of Guangdong Province
  • Key Areas of Colleges and Universities in Guangdong Province
  • National Basic Research Program of China

Zitieren

APA

Yu, B. X., Liu, Y. B., Chen, X. Y., Zhang, W., Cen, Y., Yan, M. Y., Liu, Q. Q., & Li, S. Y. (2024). Self‐Assembled PD‐L1 Downregulator to Boost Photodynamic Activated Tumor Immunotherapy Through CDK5 Inhibition. Small. https://doi.org/10.1002/smll.202311507

Vancouver

Yu BX, Liu YB, Chen XY, Zhang W, Cen Y, Yan MY, et al. Self‐Assembled PD‐L1 Downregulator to Boost Photodynamic Activated Tumor Immunotherapy Through CDK5 Inhibition. Small. 2024. doi:10.1002/smll.202311507

BibTeX
@article{Yu2024,
  author = {Yu, Bai-Xue and Liu, Yi-Bin and Chen, Xia-Yun and Zhang, Wei and Cen, Yi and Yan, Meng-Yi and Liu, Qian-Qian and Li, Shi-Ying},
  title = {Self‐Assembled PD‐L1 Downregulator to Boost Photodynamic Activated Tumor Immunotherapy Through CDK5 Inhibition},
  journal = {Small},
  year = {2024},
  doi = {10.1002/smll.202311507}
}
Kostenlos starten →